Novel Radiotherapy Shows Promise in Heavily Pretreated mCRPC Novel Radiotherapy Shows Promise in Heavily Pretreated mCRPC

A novel targeted radiolabeled small molecule appears to improve overall survival in men with metastatic castration-resistant prostate cancer (mCRPC).Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news